- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05219136
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
May 28, 2022 updated by: Zhaoshen Li, Changhai Hospital
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol:a Double-center, Prospective, Controlled Study
This double-center, prospective, interventional study aims to include 200 gastroscopic procedures and investigate the relationship between fasting time and feeling of subjects.
The subjects will all receive examination between 10:30 to 11:30am.
In the control group, the subjects are required to start the fast at 10:00pm the day before examination and can not drink water after 8:00am on the day of examination.
In the test group, the subjects are required to have customized rice congee before 6:30am on the examination day and can not drink water after 8:00am.
All subjects complete questionnaire which include discomfort and willingness to accept the same fasting regimen.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200433
- Changhai Hospital
-
-
Sichuan
-
Luzhou, Sichuan, China
- The Affiliated Traditional Chinese Medicine Hospital Of Southwest Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- No history of benign and malignant tumors (including carcinoma and adenoma) of upper GI (including esophagus, stomach and duodenum)
Exclusion Criteria:
- Subjects that cannot stand the gastroscopy procedure or cannot cooperate with endoscopists
- Emergency endoscopy and therapeutic endoscopy
- Subjects with history of esophageal or stomach surgery or endoscopic surgery
- Pregnant
- Subjects that refuse to cooperate with data collection or sign the informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional Fasting Group
In this parallel group, subjects are performed a conventional fasting protocol which requires 6-8h fasting for solid, 2h for clear liquids.
|
a conventional fasting protocol is applied to subjects.
|
Experimental: Modified Fasting Group
In this test group, a new protocol of 4h fasting for rice porridge, 2h for clear liquids is applied to subjects. The rice porridge is commercially available (New Rice Porridge®, Charm Kitchen Food Co., Ltd., Q/NBBD0001S). The volume is 300ml, with the energy as 105kJ per 100g, and it can be eaten after being heated or at room temperature. |
a new fasting protocol is applied to subjects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
subject's discomfort
Time Frame: up to 1 week
|
The feeling of the subject during the examination.
1) the score of mucosal restriction observed under gastroscope 2)the score of discomfort before gastroscopy 3)the score of discomfort during gastroscopy process.
The discomfort feeling indicator was obtained from subject through a VAS scale.
The score of mucosal restriction was obtained from endoscopists.
|
up to 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence of adverse events
Time Frame: up to 1 week
|
number of gastroscopy procedures with adverse event divided by the number of all gastroscopy procedures
|
up to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lei Xin, Dr, Changhai Hospital
- Study Chair: Luo-wei Wang, PhD, Changhai Hospital
- Principal Investigator: Li Li, Dr, The Affiliated Traditional Chinese Medicine Hospital Of Southwest Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2021
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
December 20, 2021
First Submitted That Met QC Criteria
January 20, 2022
First Posted (Actual)
February 1, 2022
Study Record Updates
Last Update Posted (Actual)
June 1, 2022
Last Update Submitted That Met QC Criteria
May 28, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- Fasting time
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fasting
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedCardiovascular Risk Factor | Athletic Performance | Fasting | Resting Energy Expenditure | Intermittent FastingUnited States
-
Desitin Arzneimittel GmbHBioPharma Services, IncCompleted
-
Beth Israel Deaconess Medical CenterCompleted
-
Gaziosmanpasa Research and Education HospitalCompleted
-
Postgraduate Institute of Medical Education and...Completed
-
Chulalongkorn UniversityCompleted
-
IPCA Laboratories Ltd.Completed
-
IPCA Laboratories Ltd.Completed
-
Dr. Reddy's Laboratories LimitedCompleted
Clinical Trials on Conventional Fasting Group
-
Universidade de Passo FundoFederal University of Rio Grande do SulCompleted
-
Changhai HospitalFirst People's Hospital of Hangzhou; LanZhou University; Ruijin Hospital; The Second... and other collaboratorsNot yet recruitingFasting | Pancreatic Duct Stone | ESWLChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityThe Hospital for Sick Children; Leiden UniversityCompleted
-
Riphah International UniversityHealth Education Research Foundation (HERF)CompletedOsteoarthritis, KneePakistan
-
Bezmialem Vakif UniversityCompletedOverweight and ObesityTurkey
-
Washington University School of MedicineCompletedObesity | OverweightUnited States
-
University of LahoreNot yet recruitingKnee Osteoarthritis
-
University of CadizCompleted
-
Universidade Cidade de Sao PauloUnknown
-
Mahidol UniversityCompleted